Search

Researchers at Washington University have published a report on the role of neuronal hyperexcitability in the growth of gliomas, a type of brain tumor. The study focused on mouse models of neurofibromatosis type 1 (NF1)-associated optic pathway glioma (OPG) and found that Nf1 mutation induces neuronal hyperexcitability and midkine expression, which supports tumor growth. The researchers also discovered that the anti-epileptic drug lamotrigine can suppress midkine production and prevent tumor progression in these models. These findings suggest that targeting neuronal hyperexcitability and midkine production could be a potential therapeutic strategy for treating gliomas. [Extracted from the article]

A study conducted by researchers at Washington University School of Medicine in St. Louis has found that the epilepsy drug lamotrigine can prevent the formation and growth of brain tumors in mice with neurofibromatosis type 1 (NF1). NF1 is a genetic condition that causes tumors to grow on nerves throughout the body, including the optic nerves. The findings of this study may lead to a clinical trial to determine if lamotrigine can prevent or delay brain tumors in children with NF1. The researchers propose a short-term treatment with the drug to reduce the chance of tumor development and the need for chemotherapy. [Extracted from the article]

A recent study conducted by researchers at Washington University in St. Louis, Missouri, explores the relationship between brain injury and the formation of optic gliomas, a type of brain tumor. The study found that brain injury can create a microenvironment that is conducive to tumor formation. The researchers identified specific cellular and molecular mechanisms involved in this process, including the release of glutamate from damaged neurons and the subsequent expression of growth factors critical for tumor formation. By interrupting these mechanisms, the progression of gliomas can be halted. This research provides valuable insights into the connection between brain injury and tumorigenesis. [Extracted from the article]

A recent study conducted by researchers at Washington University in St. Louis, Missouri, has provided new insights into optic gliomas, a type of brain tumor that can cause vision loss in children with neurofibromatosis type 1 (NF1). The study found that estrogen plays a role in the visual impairment experienced by girls with NF1, and that increased expression of a neurotoxic protein called glial interleukin-1 beta (IL-1 beta) in female mice contributes to retinal ganglion cell dysfunction. The researchers also discovered that suppressing estrogen and neutralizing IL-1 beta can improve retinal ganglion cell function, suggesting potential neuroprotective strategies for treating vision loss caused by NF1 optic gliomas. [Extracted from the article]